J Exp Clin Cancer Res 2012, 31:1756–9966 13 Zhou SL, Cui J, Fan

J Exp Clin Cancer Res 2012, 31:1756–9966. 13. Zhou SL, Cui J, Fan ZM, Li XM, Li JL, Liu BC, Zhang DY, Liu HY, Zhao XK, Song X, et al.: Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. BMC Cancer 2013, 13:1471–2407. 14. Lee E, Lee BB, Ko E, Kim Y, Han J, Shim YM, Park J, Kim DH: Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator GDC-0973 clinical trial in stage I esophageal squamous cell carcinoma. Cancer 2013, 119:1752–1760.PubMedCrossRef 15. Casadio V, Molinari C, Calistri D, Tebaldi M, Gunelli R, Serra L,

Falcini F, Zingaretti C, Silvestrini R, Amadori D, et al.: DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. J Exp Clin Cancer Res 2013, 32:94.PubMedCrossRef 16. Ma MZ, Kong X, Weng MZ, Cheng K, Gong W, Quan ZW, Peng CH: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res 2013, 32:1756–9966.CrossRef

17. Esquela-Kerscher A, Slack FJ: Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259–269.PubMedCrossRef 18. Fu HL, de Wu P, Wang XF, Wang JG, Jiao F, Song LL, Xie H, Wen XY, Shan HS, Du YX, et al.: Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma

(ESCC) in patients from Huaian, China. Cell Biochem Biophys 2013, 67:657–668.PubMedCrossRef PS-341 ic50 19. Chang Baf-A1 supplier TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al.: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745–752.PubMedCentralPubMedCrossRef 20. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6:1586–1593.PubMedCrossRef 21. Hermeking H: The miR-34 family in cancer and apoptosis. Cell Death Differ 2010, 17:193–199.PubMedCrossRef 22. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, Knyazev P, Diebold J, Hermeking H: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591–2600.PubMedCrossRef 23. Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, Jin DY, Costello JF, Liang R: Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 2010, 31:745–750.PubMedCrossRef 24. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC: Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2011, 128:132–143.PubMedCentralPubMedCrossRef 25.

Related posts:

  1. Clin Infect Dis 2012;54:e132–73 PubMedCrossRef 39 Bushby SR Tr
  2. Gastroenterology 2005, 128:1229–1242 PubMedCrossRef 11 Torres LE
  3. 2012 Aug 1;123(4):225–239 2  Lubel JS ,
  4. In some circumstances, COX inhibitors have an impact on cancer ce
  5. AP24534 Bcr-Abl inhibitor Author manuscript, increases available in PMC 2012 1 June.
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>